摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 4-bromomethyl-2-methoxymethoxybenzoate | 149543-77-1

中文名称
——
中文别名
——
英文名称
methyl 4-bromomethyl-2-methoxymethoxybenzoate
英文别名
methyl 4-(bromomethyl)-2-(methoxymethoxy)benzoate
methyl 4-bromomethyl-2-methoxymethoxybenzoate化学式
CAS
149543-77-1
化学式
C11H13BrO4
mdl
——
分子量
289.126
InChiKey
BITPTKKBOQIYHC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    373.8±42.0 °C(Predicted)
  • 密度:
    1.419±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    16
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 4-bromomethyl-2-methoxymethoxybenzoatepotassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 4,4',4''-{nitrilotris[2,1-ethanediyl(methylimino)methylene]}tris(2-methoxymethoxy-N-aminoethyl)-benzamide
    参考文献:
    名称:
    合成水杨酰胺和联吡啶的铁(II)和铁(III)配位体
    摘要:
    报道了潜在的铁螯合剂的合成和表征。两个单链结合了用于铁(II)为铁(III)的螯合的水杨酰胺和联吡啶配位体,以及三足系统已被合成。
    DOI:
    10.1016/0040-4020(96)00724-7
  • 作为产物:
    参考文献:
    名称:
    Antimicrobial effects of novel siderophores linked to β-lactam antibiotics
    摘要:
    As a strategy to increase the penetration of antibiotic drugs through the outer membrane of Gram-negative pathogens, facilitated transport through siderophore receptors has been frequently exploited. Hydroxamic acids, catechols, or very close isosteres of catechols, which are mimics of naturally occurring siderophores, have been used successfully as covalently linked escorting moieties, but a much wider diversity of iron binding motifs exists. This observation, coupled to the relative lack of specificity of siderophore receptors, prompted us to initiate a program to identify novel, noncatechol siderophoric structures. We screened over 300 compounds for their ability to (1) support growth in low iron medium of a Pseudomonas aeruginosa siderophore biosynthesis deletion mutant, or (2) compete with a bactericidal siderophore-antibiotic conjugate for siderophore receptor access. From these assays we identified a set of small molecules that fulfilled one or both of these criteria. We then synthesized these compounds with functional groups suitable for attachment to both monobactam and cephalosporin core structures. Siderophore-P-lactam conjugates then were tested against a panel of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus strains. Although several of the resultant chimeric compounds had antimicrobial activity approaching that of ceftazidime, and most compounds demonstrated very potent activity against their cellular targets, only a single compound was obtained that had enhanced, siderophore-mediated antibacterial activity. Results with tonB mutants frequently showed increased rather than decreased susceptibilities, suggesting that multiple factors influenced the intracellular concentration of the drugs. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(99)00261-8
点击查看最新优质反应信息

文献信息

  • Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
    申请人:SmithKline Beecham Corporation
    公开号:US05185351A1
    公开(公告)日:1993-02-09
    Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.
    Angiotensin II受体拮抗剂具有以下结构式:##STR1##,可用于调节高血压,并用于治疗充血性心力衰竭、肾功能衰竭和青光眼,包括这些拮抗剂的药物组合物,以及使用这些化合物在哺乳动物中产生Angiotensin II受体拮抗作用的方法。
  • Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids
    作者:Richard M. Keenan、Joseph Weinstock、Joseph A. Finkelstein、Robert G. Franz、Dimitri E. Gaitanopoulos、Gerald R. Girard、David T. Hill、Tina M. Morgan、James M. Samanen
    DOI:10.1021/jm00065a011
    日期:1993.6
    studies of these potent antagonists revealed that the thienyl ring, the (E)-acrylic acid, and the imidazole ring in addition to the two acid groups were important for high potency. Also, overlay comparisons of the parent diacid with both angiotensin II and a representative biphenylyltetrazole nonpeptide angiotensin II receptor antagonist are presented. The parent diacid analog, SK&F 108566 or (E)-3-
    详细描述了非肽血管紧张素II受体拮抗剂的咪唑5-丙烯酸系列的进一步发展(关于第1部分,请参阅:J。Med。Chem。1992,35,3858)。为了模拟血管紧张素II的Tyr4残基,进行了N-苄基环取代的修饰。在N-苄基环上引入对羧酸导致发现了对受体具有纳摩尔摩尔亲和力和良好口服活性的化合物。这些有效拮抗剂的SAR研究表明,除了两个酸性基团以外,噻吩基环,(E)-丙烯酸和咪唑环对于高效力也很重要。另外,提出了母体二酸与血管紧张素II和代表性的联苯基四唑非肽血管紧张素II受体拮抗剂的叠加比较。母体二酸类似物SK&
  • Tripodal Dodecadentate Ligands with Salicylamide and bipyridine binding sites for iron(II) and iron(III) coordination
    作者:Andreas Lutz、Thomas R. Ward
    DOI:10.1002/hlca.19980810203
    日期:1998.2.4
    The synthesis and characterization of tripodal dodecadentate ligands with salicylamide and bipyridine binding sites for iron(II) and iron(III) are presented.
    介绍了具有水杨酰胺和联吡啶结合铁(II)和铁(III)的三脚架十二齿配体的合成和表征。
  • US5185351A
    申请人:——
    公开号:US5185351A
    公开(公告)日:1993-02-09
  • US5418250A
    申请人:——
    公开号:US5418250A
    公开(公告)日:1995-05-23
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐